| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.087 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.055 | 0.2 |